If you liked this article you might like

Barbarian At The Gate: Medivation (MDVN)
Sanofi Quarterly Earnings, Sales Slide, but It Reiterates Discipline on Medivation
Here Are Some Small-Cap Pharma M&A Targets After Relypsa Deal
Investors Scour Big Pharma M&A Scene for Next Big Takeover